A citation-based method for searching scientific literature

Sheyu Li, Imola Nemeth, Louise Donnelly, Simona Hapca, Kaixin Zhou, Ewan R Pearson. Diabetes Care 2020
Times Cited: 41







List of co-cited articles
162 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
Catherine Gorst, Chun Shing Kwok, Saadia Aslam, Iain Buchan, Evangelos Kontopantelis, Phyo K Myint, Grant Heatlie, Yoon Loke, Martin K Rutter, Mamas A Mamas. Diabetes Care 2015
255
41

Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
Yoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, Toshiharu Ninomiya, Mark Cooper, Pavel Hamet, Giuseppe Mancia, Neil Poulter, Stephen Harrap, Mark Woodward,[...]. Diabetes Care 2014
198
36

Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study.
Angus Forbes, Trevor Murrells, Henrietta Mulnier, Alan J Sinclair. Lancet Diabetes Endocrinol 2018
81
29

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
26

Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial.
Chang-Sheng Sheng, Jingyan Tian, Ya Miao, Yi Cheng, Yulin Yang, Peter D Reaven, Zachary T Bloomgarden, Guang Ning. Diabetes Care 2020
35
31

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
190
24

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
19


Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
762
19

Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Andrea O Y Luk, Ronald C W Ma, Eric S H Lau, Xilin Yang, Winnie W Y Lau, Linda W L Yu, Francis C C Chow, Juliana C N Chan, Wing-Yee So. Diabetes Metab Res Rev 2013
90
17

Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
Emma S Scott, Andrzej S Januszewski, Rachel O'Connell, Gregory Fulcher, Russell Scott, Antero Kesaniemi, Linda Wu, Stephen Colagiuri, Anthony Keech, Alicia J Jenkins. J Clin Endocrinol Metab 2020
14
50

Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.
Justin B Echouffo-Tcheugui, Songzhu Zhao, Guy Brock, Roland A Matsouaka, David Kline, Joshua J Joseph. Diabetes Care 2019
56
14


HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.
C C Hsu, H Y Chang, M C Huang, S J Hwang, Y C Yang, Y S Lee, S J Shin, T Y Tai. Diabetologia 2012
65
14


Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
Giuseppe Penno, Anna Solini, Giacomo Zoppini, Emanuela Orsi, Cecilia Fondelli, Gianpaolo Zerbini, Susanna Morano, Franco Cavalot, Olga Lamacchia, Roberto Trevisan,[...]. Cardiovasc Diabetol 2013
50
12

A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
Johan Wadén, Carol Forsblom, Lena M Thorn, Daniel Gordin, Markku Saraheimo, Per-Henrik Groop. Diabetes 2009
149
12

Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study.
Julia A Critchley, Iain M Carey, Tess Harris, Stephen DeWilde, Derek G Cook. Diabetes Care 2019
31
16

Predictions of diabetes complications and mortality using hba1c variability: a 10-year observational cohort study.
Sharen Lee, Tong Liu, Jiandong Zhou, Qingpeng Zhang, Wing Tak Wong, Gary Tse. Acta Diabetol 2021
25
20

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetes Care 2020
465
12

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
934
9


Association between HbA1c variability and mortality in patients with type 2 diabetes.
Toshiko Takao, Yutaka Matsuyama, Hiroyuki Yanagisawa, Masatoshi Kikuchi, Shoji Kawazu. J Diabetes Complications 2014
38
10

HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.
Giuseppe Penno, Anna Solini, Enzo Bonora, Cecilia Fondelli, Emanuela Orsi, Gianpaolo Zerbini, Susanna Morano, Franco Cavalot, Olga Lamacchia, Luigi Laviola,[...]. Diabetes Care 2013
99
9

HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.
A Sugawara, K Kawai, S Motohashi, K Saito, S Kodama, Y Yachi, R Hirasawa, H Shimano, K Yamazaki, H Sone. Diabetologia 2012
68
9

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.
Jian-Bin Su, Li-Hua Zhao, Xiu-Lin Zhang, Hong-Li Cai, Hai-Yan Huang, Feng Xu, Tong Chen, Xue-Qin Wang. Cardiovasc Diabetol 2018
36
11


Haemoglobin A1c variability as an independent correlate of atherosclerosis and cardiovascular disease in Chinese type 2 diabetes.
Yifei Mo, Jian Zhou, Xiaojing Ma, Wei Zhu, Lei Zhang, Jie Li, Jingyi Lu, Cheng Hu, Yuqian Bao, Weiping Jia. Diab Vasc Dis Res 2018
12
33

Characteristics of people with high visit-to-visit glycaemic variability in Type 2 diabetes.
J D Noyes, E Soto-Pedre, L A Donnelly, E R Pearson. Diabet Med 2018
16
25

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
9

Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial.
Jin J Zhou, Dawn C Schwenke, Gideon Bahn, Peter Reaven. Diabetes Care 2018
64
9

Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital.
Yi-Ling Zhou, Yong-Gang Zhang, Rui Zhang, You-Lian Zhou, Nan Li, Mi-Ye Wang, Hao-Ming Tian, She-Yu Li. Chin Med J (Engl) 2021
16
25

Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial.
Matthew W Segar, Kershaw V Patel, Muthiah Vaduganathan, Melissa C Caughey, Javed Butler, Gregg C Fonarow, Justin L Grodin, Darren K McGuire, Ambarish Pandey. Diabetes Care 2020
14
28

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
9




Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial.
Antonio Ceriello, Anne Pernille Ofstad, Isabella Zwiener, Stefan Kaspers, Jyothis George, Antonio Nicolucci. Cardiovasc Diabetol 2020
13
30

Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
Eleftheria Papachristoforou, Vaia Lambadiari, Eirini Maratou, Konstantinos Makrilakis. J Diabetes Res 2020
39
10

Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes.
Yun Shen, Jian Zhou, Lizheng Shi, Elizabeth Nauman, Peter T Katzmarzyk, Eboni G Price-Haywood, Ronald Horswell, Alessandra N Bazzano, Somesh Nigam, Gang Hu. Diabetes Obes Metab 2021
8
50


Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
277
7


HbA1C variability and hypoglycemia hospitalization in adults with type 1 and type 2 diabetes: A nested case-control study.
Victor W Zhong, Juhaeri Juhaeri, Stephen R Cole, Christina M Shay, Penny Gordon-Larsen, Evangelos Kontopantelis, Elizabeth J Mayer-Davis. J Diabetes Complications 2018
17
17

Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes.
Emanuela Orsi, Anna Solini, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Cavalot, Gabriella Gruden, Susanna Morano, Antonio Nicolucci,[...]. Diabetes Obes Metab 2018
26
11

Inverse Association Between HDL (High-Density Lipoprotein) Cholesterol and Stroke Risk Among Patients With Type 2 Diabetes Mellitus.
Yun Shen, Lizheng Shi, Elizabeth Nauman, Peter T Katzmarzyk, Eboni G Price-Haywood, Alessandra N Bazzano, Somesh Nigam, Gang Hu. Stroke 2019
18
16

HbA1C variability and the risk of renal status progression in Diabetes Mellitus: a meta-analysis.
Dongsheng Cheng, Yang Fei, Yumei Liu, Junhui Li, Qin Xue, Xiaoxia Wang, Niansong Wang. PLoS One 2014
30
10

Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels.
Sarah Costantino, Francesco Paneni, Rodolfo Battista, Lorenzo Castello, Giuliana Capretti, Sergio Chiandotto, Luigi Tanese, Giulio Russo, Dario Pitocco, Gaetano A Lanza,[...]. Diabetes 2017
101
7

Visit-to-Visit Variability of Hemoglobin A1c in People Without Diabetes and Risk of Major Adverse Cardiovascular Events and All-Cause Mortality.
Jonas Ghouse, Morten W Skov, Jørgen K Kanters, Bent Lind, Jonas L Isaksen, Paul Blanche, Stig Haunsø, Lars Køber, Jesper H Svendsen, Morten S Olesen,[...]. Diabetes Care 2019
22
13



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.